TECH stock forecast
Our latest prediction for Bio-Techne Corp.'s stock price was made on the Sept. 9, 2019 when the stock price was at 183.56$.
In the short term (2weeks), TECH's stock price should outperform the market by 1.90%. During that period the price should oscillate between -3.15% and +4.53%.
In the medium term (3months), TECH's stock price should outperform the market by 1.93%. During that period the price should oscillate between -7.12% and +11.76%.Get email alerts
About Bio-Techne Corp.
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.
At the moment the company generates 714M USD in revenues.
On its last earning announcement, the company reported a profit of 2.47$ per share.
The book value per share is 28.58$
Three months stock forecastSept. 9, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|